Abstract
Preserving the functionality of hepatocytes in vitro poses a significant challenge in liver tissue engineering and bioartificial liver, as these cells rapidly lose their metabolic and functional characteristics after isolation. Inspired by the macroporous structures found in native liver tissues, here we develop synthetic hydrogel scaffolds that closely mimic the liver’s structural organization through the phase separation between polyethylene glycol (PEG) and polysaccharides. Our hydrogels exhibit interconnected macroporous structures and appropriate mechanical properties, providing an optimal microenvironment conducive to hepatocyte adhesion and the formation of sizable aggregates. Compared to two-dimensional hepatocyte cultures, enhanced functionalities of hepatocytes cultured in our macroporous hydrogels were observed for 14 days, as evidenced by quantitative reverse-transcription–polymerase chain reactions (qRT-PCR), immunofluorescence, and enzyme linked immunosorbent assay (ELISA) analyses. Protein sequencing data further confirmed the establishment of cell-cell interactions among hepatocytes when cultured in our hydrogels. Notably, these hepatocytes maintained a protein expression lineage that closely resembled freshly isolated hepatocytes, particularly in the Notch and tumor necrosis factor (TNF) signaling pathways. These results suggest that the macroporous hydrogels are attractive scaffolds for liver tissue engineering.
Similar content being viewed by others
References
Stanger, B. Z. Cellular homeostasis and repair in the mammalian liver. Annu. Rev. Physiol. 2015, 77, 179–200.
Bechmann, L. P.; Hannivoort, R. A.; Gerken, G.; Hotamisligil, G. S.; Trauner, M.; Canbay, A. The interaction of hepatic lipid and glucose metabolism in liver diseases. J. Hepatol. 2012, 56, 952–964.
Kaplowitz, N. Idiosyncratic drug hepatotoxicity. Nat. Rev. Drug Discovery 2005, 4, 489–499.
Bataller, R.; Brenner, D. A. Liver fibrosis. J. Clin. Invest. 2005, 115, 209–218.
Vosough, M.; Moslem, M.; Pournasr, B.; Baharvand, H. Cell-based therapeutics for liver disorders. Br. Med. Bull. 2011, 100, 157–172.
Nicolas, C. T.; Hickey, R. D.; Chen, H. S.; Mao, S. A.; Lopera Higuita, M.; Wang, Y. J.; Nyberg, S. L. Concise review: Liver regenerative medicine: From hepatocyte transplantation to bioartificial livers and bioengineered grafts. Stem Cells 2017, 35, 42–50.
Agarwal, T.; Subramanian, B.; Maiti, T. K. Liver tissue engineering: Challenges and opportunities. ACS Biomater. Sci. Eng. 2019, 5, 4167–4182.
Mazza, G.; Al-Akkad, W.; Rombouts, K.; Pinzani, M. Liver tissue engineering: From implantable tissue to whole organ engineering. Hepatol. Commun. 2018, 2, 131–141.
Gramignoli, R.; Vosough, M.; Kannisto, K.; Srinivasan, R. C.; Strom, S. C. Clinical hepatocyte transplantation: Practical limits and possible solutions. Eur. Surg. Res. 2015, 54, 162–177.
Jorns, C.; Ellis, E. C.; Nowak, G.; Fischler, B.; Nemeth, A.; Strom, S. C.; Ericzon, B. G. Hepatocyte transplantation for inherited metabolic diseases of the liver. J. Intern. Med. 2012, 272, 201–223.
Mirdamadi, E. S.; Kalhori, D.; Zakeri, N.; Azarpira, N.; Solati-Hashjin, M. Liver tissue engineering as an emerging alternative for liver disease treatment. Tissue Eng. Part B:Rev. 2020, 26, 145–163.
Heydari, Z.; Najimi, M.; Mirzaei, H.; Shpichka, A.; Ruoss, M.; Farzaneh, Z.; Montazeri, L.; Piryaei, A.; Timashev, P.; Gramignoli, R. et al. Tissue engineering in liver regenerative medicine: Insights into novel translational technologies. Cells 2020, 9, 304.
Tahmasbi Rad, A.; Ali, N.; Kotturi, H. S. R.; Yazdimamaghani, M.; Smay, J.; Vashaee, D.; Tayebi, L. Conducting scaffolds for liver tissue engineering. J. Biomed. Mater. Res. A 2014, 102, 4169–4181.
Hoganson, D. M.; Pryor, H. I.; Vacanti, J. P. Tissue engineering and organ structure: A vascularized approach to liver and lung. Pediatr. Res. 2008, 63, 520–526.
Li, Y. S.; Harn, H. J.; Hsieh, D. K.; Wen, T. C.; Subeq, Y. M.; Sun, L. Y.; Lin, S. Z.; Chiou, T. W. Cells and materials for liver tissue engineering. Cell Transplant. 2013, 22, 685–700.
Godoy, P.; Hewitt, N. J.; Albrecht, U.; Andersen, M. E.; Ansari, N.; Bhattacharya, S.; Bode, J. G.; Bolleyn, J.; Borner, C.; Böttger, J. et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch. Toxicol. 2013, 87, 1315–1530.
Bhatia, S. N.; Underhill, G. H.; Zaret, K. S.; Fox, I. J. Cell and tissue engineering for liver disease. Sci. Transl. Med. 2014, 6, 245sr2.
Ishibashi, H.; Nakamura, M.; Komori, A.; Migita, K.; Shimoda, S. Liver architecture, cell function, and disease. Semin. Immunopathol. 2009, 31, 399–409.
Treyer, A.; Müsch, A. Hepatocyte polarity. In Comprehensive Physiology. American Physiological Society: Rockville, 2013; pp 243–287.
Taub, R. Liver regeneration: From myth to mechanism. Nat. Rev. Mol. Cell Biol. 2004, 5, 836–847.
Godoy, P.; Hengstler, J. G.; Ilkavets, I.; Meyer, C.; Bachmann, A.; Müller, A.; Tuschl, G.; Mueller, S. O.; Dooley, S. Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor β-induced apoptosis. Hepatology 2009, 49, 2031–2043.
Arriazu, E.; Ruiz de Galarreta, M.; Cubero, F. J.; Varela-Rey, M.; Pérez de Obanos, M. P.; Leung, T. M.; Lopategi, A.; Benedicto, A.; Abraham-Enachescu, I.; Nieto, N. Extracellular matrix and liver disease. Antioxid. Redox Signal. 2014, 21, 1078–1097.
Engler, A. J.; Sen, S.; Sweeney, H. L.; Discher, D. E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126, 677–689.
Discher, D. E.; Mooney, D. J.; Zandstra, P. W. Growth factors, matrices, and forces combine and control stem cells. Science 2009, 324, 1673–1677.
Lin, G. L.; Hankenson, K. D. Integration of BMP, wnt, and notch signaling pathways in osteoblast differentiation. J. Cell. Biochem. 2011, 112, 3491–3501.
Xiang, C. G.; Du, Y. Y.; Meng, G. F.; Soon Yi, L.; Sun, S. C.; Song, N.; Zhang, X. N.; Xiao, Y. W.; Wang, J.; Yi, Z. G. et al. Long-term functional maintenance of primary human hepatocytes in vitro. Science 2019, 364, 399–402.
Batista, T. M.; Garcia-Martin, R.; Cai, W. K.; Konishi, M.; O’Neill, B. T.; Sakaguchi, M.; Kim, J. H.; Jung, D. Y.; Kim, J. K.; Kahn, C. R. Multi-dimensional transcriptional remodeling by physiological insulin in vivo. Cell Rep. 2019, 26, 3429–3443.e3.
Goldstein, I.; Yizhak, K.; Madar, S.; Goldfinger, N.; Ruppin, E.; Rotter, V. p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production. Cancer Metab. 2013, 1, 9.
Sellaro, T. L.; Ranade, A.; Faulk, D. M.; McCabe, G. P.; Dorko, K.; Badylak, S. F.; Strom, S. C. Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gels. Tissue Eng. Part A 2010, 16, 1075–1082.
Peng, H. S.; Poovaiah, N.; Forrester, M.; Cochran, E.; Wang, Q. Ex vivo culture of primary intestinal stem cells in collagen gels and foams. ACS Biomater. Sci. Eng. 2015, 1, 37–42.
Dunn, J. C. Y.; Tompkins, R. G.; Yarmush, M. L. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol. Prog. 1991, 7, 237–245.
Sidhu, J. S.; Farin, F. M.; Omiecinski, C. J. Influence of extracellular matrix overlay on phenobarbital-mediated induction of CYP2B1, 2B2, and 3A1 genes in primary adult rat hepatocyte culture. Arch. Biochem. Biophys. 1993, 301, 103–113.
Anderson, J. M.; Rodriguez, A.; Chang, D. T. Foreign body reaction to biomaterials. Semin. Immunol. 2008, 20, 86–100.
MacPherson, D.; Bram, Y.; Park, J.; Schwartz, R. E. Peptide-based scaffolds for the culture and maintenance of primary human hepatocytes. Sci. Rep. 2021, 11, 6772.
Ye, S. C.; Boeter, J. W. B.; Penning, L. C.; Spee, B.; Schneeberger, K. Hydrogels for liver tissue engineering. Bioengineering 2019, 6, 59.
Popper, H.; Schaffner, F. Liver: Structure and Function; McGraw-Hill: New York, 1957.
Bhatia, S. N.; Balis, U. J.; Yarmush, M. L.; Toner, M. Effect of cell-cell interactions in preservation of cellular phenotype: Cocultivation of hepatocytes and nonparenchymal cells. FASEB J. 1999, 13, 1883–1900.
Sato, K.; Kennedy, L.; Liangpunsakul, S.; Kusumanchi, P.; Yang, Z. H.; Meng, F. Y.; Glaser, S.; Francis, H.; Alpini, G. Intercellular communication between hepatic cells in liver diseases. Int. J. Mol. Sci. 2019, 20, 2180.
Kazemzadeh, N. M.; Ourang, F.; Soulati, H. M.; Goudarzi, A. Fabrication of porous hydroxyapatite-gelatin composite scaffolds for bone tissue engineering. Iran. Biomed. J. 2006, 10, 215–223.
Jiang, J. L.; Kojima, N.; Kinoshita, T.; Miyajima, A.; Yan, W. Q.; Sakai, Y. Cultivation of fetal liver cells in a three-dimensional poly-L-lactic acid scaffold in the presence of oncostatin M. Cell Transplant. 2002, 11, 403–406.
Mobini, S.; Hoyer, B.; Solati-Hashjin, M.; Lode, A.; Nosoudi, N.; Samadikuchaksaraei, A.; Gelinsky, M. Fabrication and characterization of regenerated silk scaffolds reinforced with natural silk fibers for bone tissue engineering. J. Biomed. Mater. Res. A 2013, 101, 2392–2404.
Broguiere, N.; Husch, A.; Palazzolo, G.; Bradke, F.; Madduri, S.; Zenobi-Wong, M. Macroporous hydrogels derived from aqueous dynamic phase separation. Biomaterials 2019, 200, 56–65.
Ma, X. Y.; Yu, C.; Wang, P. R.; Xu, W. Z.; Wan, X. Y.; Lai, C. S. E.; Liu, J.; Koroleva-Maharajh, A.; Chen, S. C. Rapid 3D bioprinting of decellularized extracellular matrix with regionally varied mechanical properties and biomimetic microarchitecture. Biomaterials 2018, 185, 310–321.
Liu, Q.; Zhao, M.; Mytnyk, S.; Klemm, B.; Zhang, K.; Wang, Y. M.; Yan, D. D.; Mendes, E.; van Esch, J. H. Self-orienting hydrogel micro-buckets as novel cell carriers. Angew. Chem. 2019, 131, 557–561.
Zhang, Y. S.; Yue, K.; Aleman, J.; Mollazadeh-Moghaddam, K.; Bakht, S. M.; Yang, J. Z.; Jia, W. T.; Dell’Erba, V.; Assawes, P.; Shin, S. R. et al. 3D bioprinting for tissue and organ fabrication. Ann. Biomed. Eng. 2017, 45, 148–163.
Ma, X. Y.; Qu, X.; Zhu, W.; Li, Y. S.; Yuan, S. L.; Zhang, H.; Liu, J.; Wang, P. R.; Lai, C. S. E.; Zanella, F. et al. Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting. Proc. Natl. Acad. Sci. USA 2016, 113, 2206–2211.
Desai, S. S.; Tung, J. C.; Zhou, V. X.; Grenert, J. P.; Malato, Y.; Rezvani, M.; Español-Suñer, R.; Willenbring, H.; Weaver, V. M.; Chang, T. T. Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4 alpha. Hepatology 2016, 64, 261–275.
Yeh, W. C.; Li, P. C.; Jeng, Y. M.; Hsu, H. C.; Kuo, P. L.; Li, M. L.; Yang, P. M.; Lee, P. H. Elastic modulus measurements of human liver and correlation with pathology. Ultrasound Med. Biol. 2002, 28, 467–474.
Kourouklis, A. P.; Kaylan, K. B.; Underhill, G. H. Substrate stiffness and matrix composition coordinately control the differentiation of liver progenitor cells. Biomaterials 2016, 99, 82–94.
Malik, R. K. Regulation of apoptosis by integrin receptors. J. Pediatr. Hematol. Oncol. 1997, 19, 541–545.
Thornberry, N. A.; Lazebnik, Y. Caspases: Enemies within. Science 1998, 281, 1312–1316.
Pinkse, G. G. M.; Voorhoeve, M. P.; Noteborn, M.; Terpstra, O. T.; Bruijn, J. A.; De Heer, E. Hepatocyte survival depends on β1-integrin-mediated attachment of hepatocytes to hepatic extracellular matrix. Liver Int. 2004, 24, 218–226.
Lapcik, L. J.; Bohdanecky, M.; Lapcik, L.; Bakos, D. ChemInform abstract: Hyaluronic acid preparation, structure, properties, application. ChemInform 1991, 22, 281–299.
Vasanthan, K. S.; Subramanian, A.; Krishnan, U. M.; Sethuraman, S. Role of biomaterials, therapeutic molecules and cells for hepatic tissue engineering. Biotechnol. Adv. 2012, 30, 742–752.
Ma, C. Y. J.; Kumar, R.; Xu, X. Y.; Mantalaris, A. A combined fluid dynamics, mass transport and cell growth model for a three-dimensional perfused biorector for tissue engineering of haematopoietic cells. Biochem. Eng. J. 2007, 35, 1–11.
Loh, Q. L.; Choong, C. Three-dimensional scaffolds for tissue engineering applications: Role of porosity and pore size. Tissue Eng. Part B Rev. 2013, 19, 485–502.
Wells, R. G. The role of matrix stiffness in regulating cell behavior. Hepatology 2008, 47, 1394–1400.
Chen, A. A.; Khetani, S. R.; Lee, S.; Bhatia, S. N.; Van Vliet, K. J. Modulation of hepatocyte phenotype in vitro via chemomechanical tuning of polyelectrolyte multilayers. Biomaterials 2009, 30, 1113–1120.
Mattei, G.; Magliaro, C.; Giusti, S.; Ramachandran, S. D.; Heinz, S.; Braspenning, J.; Ahluwalia, A. On the adhesion-cohesion balance and oxygen consumption characteristics of liver organoids. PLoS One 2017, 12, e0173206.
Xia, T. T.; Zhao, R. Z.; Liu, W. Q.; Huang, Q. P.; Chen, P. X.; Waju, Y. N.; Al-Ani, M. K.; Lv, Y. G.; Yang, L. Effect of substrate stiffness on hepatocyte migration and cellular Young’s modulus. J. Cell. Physiol. 2018, 233, 6996–7006.
Cozzolino, A. M.; Noce, V.; Battistelli, C.; Marchetti, A.; Grassi, G.; Cicchini, C.; Tripodi, M.; Amicone, L. Modulating the substrate stiffness to manipulate differentiation of resident liver stem cells and to improve the differentiation state of hepatocytes. Stem Cells Int. 2016, 2016, 5481493.
Deegan, D. B.; Zimmerman, C.; Skardal, A.; Atala, A.; Shupe, T. D. Stiffness of hyaluronic acid gels containing liver extracellular matrix supports human hepatocyte function and alters cell morphology. J. Mech. Behav. Biomed. Mater. 2016, 55, 87–103.
Passi, M.; Zahler, S. Mechano-signaling aspects of hepatocellular carcinoma. J. Cancer 2021, 12, 6411–6421.
You, J.; Park, S. A.; Shin, D. S.; Patel, D.; Raghunathan, V. K.; Kim, M.; Murphy, C. J.; Tae, G.; Revzin, A. Characterizing the effects of heparin gel stiffness on function of primary hepatocytes. Tissue Eng. Part A 2013, 19, 2655–2663.
Kidambi, S.; Yarmush, R. S.; Novik, E.; Chao, P. Y.; Yarmush, M. L.; Nahmias, Y. Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance. Proc. Natl. Acad. Sci. USA 2009, 106, 15714–15719.
Spinella, R.; Sawhney, R.; Jalan, R. Albumin in chronic liver disease: Structure, functions and therapeutic implications. Hepatol. Int. 2016, 10, 124–132.
Fairbanks, K. D.; Tavill, A. S. Liver disease in alpha 1-antitrypsin deficiency: A review. Am. J. Gastroenterol. 2008, 103, 2136–2141.
Park, M. J.; D’Alecy, L. G.; Anderson, M. A.; Basrur, V.; Feng, Y. J.; Brady, G. F.; Kim, D. I.; Wu, J.; Nesvizhskii, A. I.; Lahann, J. Constitutive release of CPS1 in bile and its role as a protective cytokine during acute liver injury. Proc. Natl. Acad. Sci. USA 2019, 116, 9125–9134.
Villeneuve, J. P.; Pichette, V. Cytochrome P450 and liver diseases. Curr. Drug Metab. 2004, 5, 273–282.
Congiu, M.; Mashford, M. L.; Slavin, J. L.; Desmond, P. V. UDP glucuronosyltransferase mRNA levels in human liver disease. Drug Metab. Dispos. 2002, 30, 129–134.
Adams, J. M.; Jafar-Nejad, H. The roles of notch signaling in liver development and disease. Biomolecules 2019, 9, 608.
Fiorotto, R.; Raizner, A.; Morell, C. M.; Torsello, B.; Scirpo, R.; Fabris, L.; Spirli, C.; Strazzabosco, M. Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice. J. Hepatol. 2013, 59, 124–130.
Lu, J.; Zhou, Y. Q.; Hu, T. Y.; Zhang, H.; Shen, M.; Cheng, P.; Dai, W. Q.; Wang, F.; Chen, K.; Zhang, Y. et al. Notch signaling coordinates progenitor cell-mediated biliary regeneration following partial hepatectomy. Sci. Rep. 2016, 6, 22754.
Chen, Y. X.; Zheng, S. P.; Qi, D.; Zheng, S. J.; Guo, J. L.; Zhang, S. L.; Weng, Z. H. Inhibition of notch signaling by a γ-secretase inhibitor attenuates hepatic fibrosis in rats. PLoS One 2012, 7, e46512.
Kawaguchi, K.; Kaneko, S. Notch signaling and liver cancer. In Notch Signaling in Embryology and Cancer: Notch Signaling in Cancer. Springer: Cham 2021, 69–80.
Wullaert, A.; van Loo, G.; Heyninck, K.; Beyaert, R. Hepatic tumor necrosis factor signaling and nuclear factor-κB: Effects on liver homeostasis and beyond. Endocr. Rev. 2007, 28, 365–386.
Hatano, E. Tumor necrosis factor signaling in hepatocyte apoptosis. J. Gastroenterol. Hepatol. 2007, 22, S43–S44.
Czaja, M. J. Cell signaling in oxidative stress-induced liver injury. Semin. Liver Dis. 2007, 27, 378–389.
Yang, Y. M.; Seki, E. TNFα in liver fibrosis. Curr. Pathobiol. Rep. 2015, 3, 253–261.
de Hoyos-Vega, J. M.; Hong, H. J.; Stybayeva, G.; Revzin, A. Hepatocyte cultures: From collagen gel sandwiches to microfluidic devices with integrated biosensors. APL Bioeng. 2021, 5, 041504.
Khetani, S. R.; Bhatia, S. N. Microscale culture of human liver cells for drug development. Nat. Biotechnol. 2008, 26, 120–126.
Ploss, A.; Khetani, S. R.; Jones, C. T.; Syder, A. J.; Trehan, K.; Gaysinskaya, V. A.; Mu, K.; Ritola, K.; Rice, C. M.; Bhatia, S. N. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc. Natl. Acad. Sci. USA 2010, 107, 3141–3145.
Wu, D. D.; Lei, H.; Xie, X.; Zhou, L.; Zheng, P.; Cao, Y.; Zhang, Y. Self-sorting double network hydrogels with photo-definable biochemical cues as artificial synthetic extracellular matrix. Nano Res. 2022, 15, 4294–4301.
Ng, S. S.; Xiong, A. M.; Nguyen, K.; Masek, M.; No, D. Y.; Elazar, M.; Shteyer, E.; Winters, M. A.; Voedisch, A.; Shaw, K. et al. Long-term culture of human liver tissue with advanced hepatic functions. JCI Insight 2017, 2, e90853.
No, D. Y.; Lee, K. H.; Lee, J.; Lee, S. H. 3D liver models on a microplatform: Well-defined culture, engineering of liver tissue and liver-on-a-chip. Lab Chip 2015, 15, 3822–3837.
Schepers, A.; Li, C. R.; Chhabra, A.; Seney, B. T.; Bhatia, S. Engineering a perfusable 3D human liver platform from iPS cells. Lab Chip 2016, 16, 2644–2653.
Klaas, M.; Möll, K.; Mäemets-Allas, K.; Loog, M.; Järvekülg, M.; Jaks, V. Long-term maintenance of functional primary human hepatocytes in 3D gelatin matrices produced by solution blow spinning. Sci. Rep. 2021, 11, 20165.
Kim, M. H.; Kumar, S. K.; Shirahama, H.; Seo, J.; Lee, J. H.; Cho, N. J. Phenotypic regulation of liver cells in a biofunctionalized three-dimensional hydrogel platform. Integr. Biol. 2016, 8, 156–166.
Ruoß, M.; Häussling, V.; Schügner, F.; Olde Damink, L. H. H.; Lee, S. M. L.; Ge, L. M.; Ehnert, S.; Nussler, A. K. A standardized collagen-based scaffold improves human hepatocyte shipment and allows metabolic studies over 10 days. Bioengineering 2018, 5, 86.
Genové, E.; Schmitmeier, S.; Sala, A.; Borrós, S.; Bader, A.; Griffith, L. G.; Semino, C. E. Functionalized self-assembling peptide hydrogel enhance maintenance of hepatocyte activity in vitro. J. Cell. Mol. Med. 2009, 13, 3387–3397.
Wu, J.; Marí-Buyé, N.; Muiños, T. F.; Borrós, S.; Favia, P.; Semino, C. E. Nanometric self-assembling peptide layers maintain adult hepatocyte phenotype in sandwich cultures. J. Nanobiotechnol. 2010, 8, 29.
Stevens, K. R.; Scull, M. A.; Ramanan, V.; Fortin, C. L.; Chaturvedi, R. R.; Knouse, K. A.; Xiao, J. W.; Fung, C.; Mirabella, T.; Chen, A. X. et al. In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease. Sci. Transl. Med. 2017, 9, eaah5505.
Stabler, C. L.; Giraldo, J. A.; Berman, D. M.; Gattás-Asfura, K. M.; Willman, M. A.; Rabassa, A.; Geary, J.; Diaz, W.; Kenyon, N. M.; Kenyon, N. S. Transplantation of PEGylated islets enhances therapeutic efficacy in a diabetic nonhuman primate model. Am. J. Transplant. 2020, 20, 689–700.
Bose, S.; Volpatti, L. R.; Thiono, D.; Yesilyurt, V.; McGladrigan, C.; Tang, Y. Y.; Facklam, A.; Wang, A.; Jhunjhunwala, S.; Veiseh, O. et al. A retrievable implant for the long-term encapsulation and survival of therapeutic xenogeneic cells. Nat. Biomed. Eng. 2020, 4, 814–826.
Coronel, M. M.; Martin, K. E.; Hunckler, M. D.; Barber, G.; O’Neill, E. B.; Medina, J. D.; Opri, E.; McClain, C. A.; Batra, L.; Weaver, J. D. et al. Immunotherapy via PD-L1-presenting biomaterials leads to long-term islet graft survival. Sci. Adv. 2020, 6, eaba5573.
Madhurakkat Perikamana, S. K.; Seale, N.; Hoque, J.; Ryu, J. H.; Kumar, V.; Shih, Y. V.; Varghese, S. Molecularly tailored interface for long-term xenogeneic cell transplantation. Adv. Funct. Mater. 2022, 32, 2108221.
Hu, H. L.; Gehart, H.; Artegiani, B.; Löpez-Iglesias, C.; Dekkers, F.; Basak, O.; van Es, J.; de Sousa Lopes, S. M. C.; Begthel, H.; Korving, J. et al. Long-term expansion of functional mouse and human hepatocytes as 3D organoids. Cell 2018, 175, 1591–1606.e19.
Zhao, Z. X.; Chen, X. Y.; Dowbaj, A. M.; Sljukic, A.; Bratlie, K.; Lin, L. D.; Fong, E. L. S.; Balachander, G. M.; Chen, Z. W.; Soragni, A. et al. Organoids. Nat. Rev. Methods Primers 2022, 2, 94.
Lei, H.; Dong, L.; Li, Y.; Zhang, J. S.; Chen, H. Y.; Wu, J. H.; Zhang, Y.; Fan, Q. Y.; Xue, B.; Qin, M. et al. Stretchable hydrogels with low hysteresis and anti-fatigue fracture based on polyprotein cross-linkers. Nat. Commun. 2020, 11, 4032.
Cao, H.; Duan, L. X.; Zhang, Y.; Cao, J.; Zhang, K. Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity. Signal Transduct. Target. Ther. 2021, 6, 426.
Mu, Q. F.; Cui, K. P.; Wang, Z. J.; Matsuda, T.; Cui, W.; Kato, H.; Namiki, S.; Yamazaki, T.; Frauenlob, M.; Nonoyama, T. et al. Force-triggered rapid microstructure growth on hydrogel surface for on-demand functions. Nat. Commun. 2022, 13, 6213.
Charni-Natan, M.; Goldstein, I. Protocol for primary mouse hepatocyte isolation. STAR Protoc. 2020, 1, 100086.
Acknowledgements
This work is funded by the National Key R&D Program of China (No. 2020YFA0908100); the Research Project of Jinan Microecological Biomedicine Shandong Laboratory (Nos. JNL2022004A, JNL2022019B); Shandong Provincial Laboratory Project (No. SYS202202).
Author information
Authors and Affiliations
Corresponding authors
Electronic Supplementary Material
12274_2023_5940_MOESM1_ESM.pdf
Long-term functional maintenance of primary hepatocytes in vitro using macroporous hydrogels engineered through liquid-liquid phase separation
Rights and permissions
About this article
Cite this article
Sun, Y., Yin, S., Cui, J. et al. Long-term functional maintenance of primary hepatocytes in vitro using macroporous hydrogels engineered through liquid-liquid phase separation. Nano Res. 17, 1725–1736 (2024). https://doi.org/10.1007/s12274-023-5940-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12274-023-5940-3